EMEA-001821-PIP01-15-M06
EMEA-001821-PIP01-15-M06
EMEA-001821-PIP01-15-M06
Opinion/decision on a Paediatric investigation plan (PIP): Trixeo Aerosphere, Budesonide,Formoterol (fumarate),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0068/2023
Opinion/decision on a Paediatric investigation plan (PIP): Evrysdi, Risdiplam (RO7034067), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0086/2023
EMEA-002079-PIP01-16-M03
EMEA-003170-PIP01-21-M01
EMEA-000334-PIP01-08-M11
Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, Tofacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0102/2023
Opinion/decision on a Paediatric investigation plan (PIP): Uptravi, Selexipag, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0088/2023
Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0063/2023
EMEA-003238-PIP01-22